REGINA FREDERICK: Open Payments
NPI 1447731302 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,490 in 121 payments from 11 companies in 2025. Trend: 2023 $1,835 · 2024 $1,000 · 2025 $2,490
Food & beverage: $2,430Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 72 | $1,534 |
| Novartis Pharmaceuticals Corporation | 12 | $229 |
| Amgen Inc. | 16 | $200 |
| GlaxoSmithKline, LLC. | 6 | $190 |
| Janssen Biotech, Inc. | 4 | $117 |
| UCB, Inc. | 4 | $69 |
| SOBI, INC | 2 | $47 |
| Lilly USA, LLC | 2 | $43 |
| GENZYME CORPORATION | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
Products named: RINVOQ, SKYRIZI, COSENTYX, BENLYSTA, TREMFYA, OTEZLA, Bimzelx, Kineret.
Industry payments across IN — which companies pay providers there.
